Epidemiology


Etiology


Pathophysiology


Clinical features

  • Chronic, relapsing abdominal pain: Often crampy and located in the lower abdomen.
  • Altered bowel habits: The primary feature used for subtyping.
    • IBS-C: Predominantly constipation.
    • IBS-D: Predominantly diarrhea.
    • IBS-M: Mixed diarrhea and constipation.
  • Symptom characteristics: Pain is typically related to defecation (may improve or worsen), associated with a change in stool frequency or form.
  • Other common S/S: Bloating, abdominal distension, sensation of incomplete evacuation, and mucus in stool.
  • Exacerbating factors: Symptoms are often worsened by stress and certain foods.

Diagnostics

Rome IV criteria for irritable bowel syndrome

  • Timing: ≥ 6 months since the onset of symptoms
  • Symptoms
    • Recurrent abdominal pain (≥ 1 day per week during the previous 3 months)
    • PLUS ≥ 2 of the following
      • Abdominal pain related to defecation
      • Change in stool frequency
      • Change in appearance of stool

Treatment

  • Lifestyle & Diet (First-line):
    • Patient education and reassurance.
    • Dietary modification: Trial of a low FODMAP diet (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols) is effective for global symptoms.
    • Fiber: Soluble fiber (e.g., psyllium) can help with global symptoms, particularly in IBS-C. Insoluble fiber (e.g., bran) may worsen bloating.
  • Pharmacotherapy (Symptom-directed):
    • IBS-D: Loperamide for episodes of diarrhea. Rifaximin (a non-absorbable antibiotic) and Eluxadoline (a mixed opioid receptor agonist) are second-line options.
    • IBS-C: Laxatives (e.g., polyethylene glycol). Secretagogues like Lubiprostone (chloride channel activator) and Linaclotide (guanylate cyclase-C agonist) are effective.
    • Abdominal Pain/Spasms: Antispasmodics (e.g., dicyclomine, hyoscyamine), peppermint oil.
    • Neuromodulators: Low-dose Tricyclic Antidepressants (TCAs) (e.g., amitriptyline) are effective for pain and global symptoms.